#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA656067	F	Concentration required to reduce proliferation of CD4+ human acuteT-lymphoblastic leukemia (CCRF-CEM) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
2.	ALA651471	F	Concentration required to reduce proliferation of human acute B-lymphoblastic (CCRF-SB) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
3.	ALA653612	F	Concentration required to reduce proliferation of human foreskin fibroblasts (CRL7065) cell line by 50% as determined by the MTT method; nd = not determined	Homo sapiens	8	ALA1148410	cell-based format	Scientific Literature
4.	ALA668067	F	Concentration required to reduce proliferation of human prostate carcinoma (DU-145) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
5.	ALA696818	F	Concentration required to reduce proliferation of human hepatocellular carcinoma (HepG-2) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
6.	ALA703879	F	Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method	Homo sapiens	5	ALA1148410	cell-based format	Scientific Literature
7.	ALA703880	F	Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method	Homo sapiens	5	ALA1148410	cell-based format	Scientific Literature
8.	ALA701391	F	Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method	Homo sapiens	5	ALA1148410	cell-based format	Scientific Literature
9.	ALA702198	F	Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method	Homo sapiens	5	ALA1148410	cell-based format	Scientific Literature
10.	ALA710209	F	Concentration required to reduce proliferation of human breast adenocarcinoma (MCF-7) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
11.	ALA713939	F	Concentration required to reduce proliferation of CD4+ human acute T-lymphoblastic leukemia (MT-4) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
12.	ALA873247	F	Concentration required to reduce proliferation of human breast adenocarcinoma (SKMEL-28) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
13.	ALA882602	F	Concentration required to reduce proliferation of human lung squamous carcinoma (SKMES-1) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature
14.	ALA822285	F	Concentration required to reduce proliferation of human splenic B-lymphoblastoid (Wil2-NS) cell line by 50% as determined by the MTT method	Homo sapiens	17	ALA1148410	cell-based format	Scientific Literature